C12N 2800/70
Vectors containing special elements for cloning
Official title: Vectors containing special elements for cloning, e.g. topoisomerase, adaptor sites
C12N2800/70 (Vectors containing special elements for cloning) appears on 51 US grants and 79 published applications in this corpus.
Search patents in C12N- Granted patents
- 51
- Published applications
- 79
- Assignees
- 40
- Inventors
- 124
- Latest grant
- 14 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1996 | 2 | 0 |
| 1997 | 3 | 0 |
| 1998 | 2 | 0 |
| 1999 | 2 | 0 |
| 2000 | 1 | 0 |
| 2001 | 2 | 0 |
| 2002 | 0 | 1 |
| 2003 | 0 | 1 |
| 2004 | 1 | 2 |
| 2005 | 0 | 3 |
| 2006 | 2 | 0 |
| 2007 | 1 | 1 |
| 2008 | 0 | 3 |
| 2009 | 0 | 2 |
| 2010 | 1 | 0 |
| 2011 | 1 | 2 |
| 2012 | 2 | 2 |
| 2013 | 0 | 5 |
| 2014 | 1 | 1 |
| 2015 | 2 | 5 |
| 2016 | 1 | 3 |
| 2017 | 0 | 5 |
| 2018 | 3 | 5 |
| 2019 | 2 | 3 |
| 2020 | 3 | 8 |
| 2021 | 2 | 5 |
| 2022 | 7 | 8 |
| 2023 | 2 | 2 |
| 2024 | 4 | 3 |
| 2025 | 2 | 4 |
| 2026 | 2 | 5 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Nucleic acid molecules containing spacers and methods of use thereof14 Apr 2026US 12,600,986 B2Astellas Gene Therapies, Inc.
- Circular RNA for translation in eukaryotic cells10 Mar 2026US 12,570,996 B2Massachusetts Institute of Technology
- Circular RNA for translation in eukaryotic cells30 Dec 2025US 12,509,701 B2Massachusetts Institute of Technology
- Nucleic acid therapeutics for genetic disorders26 Aug 2025US 12,397,012 B2GreenLight Biosciences, Inc.
- Promoter for heterologous expression20 Aug 2024US 12,065,652 B2BASF SE
- Hsv gene expression vector and bxb1 integrase-mediated recombination system for high-throughput cloning27 Aug 2026US 2026/0250643 A1Albert Einstein College of Medicine
- Binary Self-Amplifying Nucleic Acid Platform and Uses Thereof4 Jun 2026US 2026/0152760 A1
- Circular RNA For Translation In Eukaryotic Cells30 Apr 2026US 2026/0117252 A1Massachusetts Institute of Technology
- Circular RNA For Translation In Eukaryotic Cells19 Mar 2026US 2026/0078400 A1Massachusetts Institute of Technology
- Method for preparing linear closed dna and plasmid for use in the method26 Feb 2026US 2026/0055392 A1Zhenjiang Probio Biotech Co., Ltd.
Most cited
By later US patents
- Ransgenic non-human animals for producing heterologous antibodies1,941US 5,545,806 AGenPharm International, Inc. · 1996
- Transgenic non-human animals capable of producing heterologous antibodies1,680US 5,633,425 AGenPharm International, Inc. · 1997
- Transgenic non-human animals for producing heterologous antibodies1,604US 5,625,126 AGenPharm International, Inc. · 1997
- Transgenic non-human animals capable of producing heterologous antibodies950US 5,770,429 AGenPharm International, Inc. · 1998
- Transgenic non-human animals for producing heterologous antibodies679US 5,814,318 AGenPharm International, Inc. · 1998